Genome-wide CRISPR/Cas9 screening for drug resistance in tumors

Genome-wide CRISPR/Cas9 screening for drug resistance in tumors

Genome-wide clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated nuclease 9 (Cas9) screening is a simple screening method for locating loci under specific conditions, and it has been utilized in tumor drug resistance research for finding potential drug resistance-asso...

Full description

Bibliographic Details
Main Authors: Zhongyan Zhang, Hailiang Wang, Qian Yan, Jinwei Cui, Yubin Chen, Shiye Ruan, Jiayu Yang, Zelong Wu, Mingqian Han, Shanzhou Huang, Qi Zhou, Chuanzhao Zhang, Baohua Hou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Pharmacology
Subjects:
drug resistance
tumors
genome-wide CRISPR/Cas9 screening
MAPK pathway inhibitors
PARP inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1284610/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1284610/full

Similar Items